Gaggar Anuj
Chief Medical Officer
Gaggar Anuj has filed 3 SEC Form 4 filings (5 transaction rows) across 1 company, with disclosures dating back to 2026. 3 of those filings fall inside the rolling window. Most recent filing: Nov 3, 2026.
On the most recent filing, Gaggar Anuj is listed as Chief Medical Officer at ASSEMBLY BIOSCIENCES, INC. Inside the rolling window, Gaggar Anuj reported no open-market purchases and 1 open-market sale totaling $51K in ASMB.
Companies traded
Other insiders at ASMB
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$51K
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has Gaggar Anuj made?
Gaggar Anuj has filed 3 SEC Form 4 filings (5 transaction rows) across 1 company since 2026.
Which companies does Gaggar Anuj trade?
Gaggar Anuj has filed SEC Form 4 disclosures for 1 company, including ASMB.
When was Gaggar Anuj's most recent SEC Form 4 filing?
Gaggar Anuj's most recent SEC Form 4 filing on Tracefour is dated Nov 3, 2026.
What is Gaggar Anuj's job title?
On the most recent SEC Form 4 filings tracked by Tracefour, Gaggar Anuj is listed as Chief Medical Officer.
What is Gaggar Anuj's total buy and sell value in the current window?
Inside the rolling retention window, Gaggar Anuj bought $0 and sold $51K based on SEC Form 4 filings.
What was Gaggar Anuj's largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 2,593 ASMB shares on 2026-11-02, worth $51K, per SEC Form 4 filings.